European consensus table on the use of botulinum toxin type a in adult spasticity

Jörg Wissel, Anthony B. Ward, Per Erztgaard, Djamel Bensmail, Martin J. Hecht, Thierry M. Lejeune, Peter Schnider, Maria C. Altavista, Stefano Cavazza, Thierry Deltombe, Esther Duarte, Alexander C H Geurts, Jean Michel Gracies, Naseer H J Haboubi, Francisco J. Juan, Helge Kasch, Christian Kätterer, Yeşim Kirazli, Paolo Manganotti, Yeşim ParmanTatjana Paternostro-Sluga, Konstantina Petropoulou, Robert Prempeh, Marc Rousseaux, Jaroslaw Slawek, Niko Tieranta

Research output: Contribution to journalArticlepeer-review

Abstract

A group of clinicians from across Europe experienced in the use of botulinum toxin type A for the treatment of spasticity following acquired brain injury gathered to develop a consensus statement on best practice in managing adults with spasticity. This consensus table summarizes the current published data, which was collated following extensive literature searches, their assessment for level of evidence and discussion among the whole group. Published information is supplemented by expert opinion based on clinical experience from 16 European countries, involving 28 clinicians, who treat an average of approximately 200 patients annually, representing many thousand spasticity treatments with botulinum toxin per year.

Original languageEnglish
Pages (from-to)13-25
Number of pages13
JournalJournal of Rehabilitation Medicine
Volume41
Issue number1
DOIs
Publication statusPublished - Jan 2009

Keywords

  • Acquired brain injury
  • Adult spasticity
  • Botulinum toxin
  • Upper motor neurone syndrome

ASJC Scopus subject areas

  • Rehabilitation
  • Physical Therapy, Sports Therapy and Rehabilitation

Fingerprint Dive into the research topics of 'European consensus table on the use of botulinum toxin type a in adult spasticity'. Together they form a unique fingerprint.

Cite this